This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Eiger BioPharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 26 Jun 24 | SellUS$1,029,771 | Moshe Arkin | Individual | 96,300 | US$13.17 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 148,773 | 10% |
| Individual Insiders | 251,175 | 17% |
| General Public | 1,080,849 | 73% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 149,371 | US$1.3m | 181% | no data | |||
| 90,000 | US$765.0k | 0% | 0.06% | |||
| 56,381 | US$479.2k | 0% | 0.67% | |||
| 32,793 | US$278.7k | 0% | no data | |||
| 31,032 | US$263.8k | 8,360% | no data | |||
| 11,296 | US$96.0k | 0% | no data | |||
| 5,971 | US$50.8k | 0% | no data | |||
| 5,551 | US$47.2k | 197% | no data | |||
| 5,365 | US$45.6k | 127% | no data | |||
| 4,000 | US$34.0k | 0% | no data | |||
| 1,466 | US$12.5k | 214% | no data | |||
| 1,466 | US$12.5k | 175% | no data | |||
| 1,133 | US$9.6k | 467% | no data | |||
| 1,116 | US$9.5k | 0% | 0.01% | |||
| 1,080 | US$9.2k | 0% | no data | |||
| 714 | US$6.1k | 0% | no data | |||
| 650 | US$5.5k | 0% | no data | |||
| 367 | US$3.1k | 0% | no data | |||
| 81 | US$688.5 | 0% | no data | |||
| 63 | US$534.9 | 0% | no data | |||
| 43 | US$365.0 | -82.8% | no data | |||
| 9 | US$76.8 | 0% | no data |